Literature DB >> 15920758

Involvement of axonal guidance proteins and their signaling partners in the developing mouse mammary gland.

Joanna S Morris1, Torsten Stein, Marie-Anne Pringle, Claire R Davies, Stephen Weber-Hall, Roderick K Ferrier, Alexandra K Bell, Victoria J Heath, Barry A Gusterson.   

Abstract

Mammary morphogenesis in the mouse is driven by specialized structures at the ends of the developing ducts, the terminal end buds (TEB). The mechanisms controlling the precise branching and spacing of the ducts are, as yet, unknown. To identify genes that are associated with migration of TEB and differentiation of the subtending ducts, we developed a novel method of isolating TEB and ducts free of stroma, and compared the gene expression profiles of these two isolates using oligonucleotide microarrays. Ninety one genes were upregulated in TEB compared to ducts. Three of these genes, Sprr1A, Sema3B, and BASP1, are associated with axonal growth and guidance. Two additional members of the Sprr family, Sprr2A and 2B, not previously associated with axonal growth, were also highly expressed in TEB. Expression of these genes was confirmed by RT-PCR and Western blotting, and the cellular distribution of Sprr1A and BASP1 was demonstrated by immunohistochemistry. Other semaphorins, including Sema3C, 4A, 4F and the cancer invasion associated Sema 4D were also expressed in the mouse mammary gland along with the semaphorin receptors, Plexins A2, A3, B2, and D1, and Neuropilins 1 and 2. These results are discussed in the context of other proteins expressed in the developing gland that are known to be downstream effectors of these signaling molecules. We suggest that these genes may influence ductal growth and morphogenesis in the developing mammary gland. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15920758     DOI: 10.1002/jcp.20427

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  26 in total

1.  Alterations of gene expression in the development of early hyperplastic precursors of breast cancer.

Authors:  Sangjun Lee; Dan Medina; Anna Tsimelzon; Syed K Mohsin; Sufeng Mao; Yun Wu; D Craig Allred
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

Review 2.  Navigating breast cancer: axon guidance molecules as breast cancer tumor suppressors and oncogenes.

Authors:  Gwyndolen C Harburg; Lindsay Hinck
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-08-05       Impact factor: 2.673

3.  BASP1 promotes apoptosis in diabetic nephropathy.

Authors:  Maria Dolores Sanchez-Niño; Ana Belen Sanz; Corina Lorz; Andrea Gnirke; Maria Pia Rastaldi; Viji Nair; Jesus Egido; Marta Ruiz-Ortega; Matthias Kretzler; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2010-01-28       Impact factor: 10.121

4.  In-silico QTL mapping of postpubertal mammary ductal development in the mouse uncovers potential human breast cancer risk loci.

Authors:  Darryl L Hadsell; Louise A Hadsell; Walter Olea; Monique Rijnkels; Chad J Creighton; Ian Smyth; Kieran M Short; Liza L Cox; Timothy C Cox
Journal:  Mamm Genome       Date:  2015-01-01       Impact factor: 2.957

5.  Clinical significance of SPRR1A expression in progesterone receptor-positive breast cancer.

Authors:  Guanglei Chen; Gang Li; Minna Luo; Xiaofei Wei; Dan Wang; Hao Zhang; Xinhan Zhao; Bo Chen; Caigang Liu
Journal:  Tumour Biol       Date:  2014-11-26

Review 6.  Diverse functions for the semaphorin receptor PlexinD1 in development and disease.

Authors:  Carl M Gay; Tomasz Zygmunt; Jesús Torres-Vázquez
Journal:  Dev Biol       Date:  2010-09-27       Impact factor: 3.582

7.  Fibulin-2 is involved in early extracellular matrix development of the outgrowing mouse mammary epithelium.

Authors:  D Olijnyk; A M Ibrahim; R K Ferrier; T Tsuda; M-L Chu; B A Gusterson; T Stein; J S Morris
Journal:  Cell Mol Life Sci       Date:  2014-02-13       Impact factor: 9.261

8.  Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer.

Authors:  Yi Ding; Dandan He; Diego Florentin; Anna Frolov; Sue Hilsenbeck; Michael Ittmann; Dov Kadmon; Brian Miles; David Rowley; Gustavo Ayala
Journal:  Clin Cancer Res       Date:  2013-10-04       Impact factor: 12.531

9.  Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes.

Authors:  Anthony J Demetris; Susan Specht; Isao Nozaki; John G Lunz; Donna Beer Stolz; Noriko Murase; Tong Wu
Journal:  J Hepatol       Date:  2007-12-17       Impact factor: 25.083

10.  Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.

Authors:  Isabelle Mercier; Mathew C Casimiro; Jie Zhou; Chenguang Wang; Christopher Plymire; Kelly G Bryant; Kristin M Daumer; Federica Sotgia; Gloria Bonuccelli; Agnieszka K Witkiewicz; Justin Lin; Thai Hong Tran; Janet Milliman; Philippe G Frank; Jean-François Jasmin; Hallgeir Rui; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2009-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.